慢性肺部感染中的抗菌素耐药性:通往耐药性的道路
Wang Chun Kwok1, Katharine Pates2, Anand Shah3,4
1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong.
Thorax
|July 7, 2025
概括
慢性肺部感染中抗菌素耐药性 (AMR) 是一个主要的健康威胁. 需要新的治疗方法和更好的抗生素管理来打击耐药细菌并改善患者的治疗结果.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 肺部医学 肺部医学
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球重大健康挑战,特别是对于患有支气管病,囊性纤维化和COPD等慢性肺部疾病的人来说.
- 这些情况往往涉及反复的细菌感染,导致抗生素使用增加和患AMR的风险更高.
研究的目的:
- 本综述探讨了AMR和慢性细菌性肺部感染之间的复杂关系.
- 它涵盖了病原体流行病学,诊断方法,耐药性的临床影响和治疗效果,概述了未来的研究和治疗方向.
主要方法:
- 对慢性肺部感染中AMR现有理解的文献综述.
- 对病原体耐药机制,诊断技术和治疗策略的分析.
主要成果:
- 像Pseudomonas aeruginosa和Staphylococcus aureus这样的关键病原体表现出多样化的抗药机制,AMR与疾病严重程度和死亡率的增加有关.
- 长期的抗生素治疗可以改善结果,但可能会导致耐药性,需要谨慎管理.
- 传统的诊断与多微生物感染作斗争;像测序这样的先进方法显示出希望,但需要进一步的临床开发.
结论:
- 慢性肺部感染中的AMR是一个复杂的,不断变化的问题,需要新的解决方案.
- 新兴的疗法,如菌体和精密医学,具有潜力,但需要验证.
- 加强管理和个性化治疗对于缓解AMR和改善患者护理至关重要.
相关概念视频
01:30Development of Antibiotic Resistance
219
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
219
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:31Defense Against Bacterial Pathogens
1.5K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
01:28Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243